Teva Pharmaceutical Industries LtdTEVA:TLV

23,180
20.00 / 0.09%
183.63k
49.84%
0.6562
Close in ILAToday's changeShares traded1 year changeBeta
Data delayed at least 20 minutes, as of Jan 28 2015 15:24 GMT.

Summary

On Wednesday, Teva Pharmaceutical Industries Ltd (TEVA:TLV) closed at 23,180, 2.48% below its 52-week high of 23,770, set on Jan 26, 2015.

52-week range
Today
15,220
Feb 10 2014
23,770
Jan 26 2015
Open23,300
Day high23,460
Day low23,180
Bid23,180
Offer23,200
Previous close23,200
Average volume477.56k
Shares outstanding956.55m
Free float942.13m
P/E (TTM)18.12
Market cap219.60bn ILS
EPS (TTM)12.67 ILS
Annual div (TTM)411.40 ILA
Annual div yield (TTM)1.77%
Div ex-dateNov 17 2014
Div pay-dateDec 02 2014
Data delayed at least 20 minutes, as of Jan 28 2015 15:24 GMT.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Teva Pharmaceutical Industries Ltd+0.96%+3.16%+23.36%+49.84%+9.13%
TASE TA-100 IDX+0.18%-0.90%+1.86%+5.63%+19.03%
IL/HEALTH CARE+1.03%+3.58%+19.74%+33.32%+8.45%
IL/PHARMACEUTICALS+1.03%+3.58%+19.74%+33.32%+8.45%
Data delayed at least 20 minutes, as of Jan 28 2015 15:24 GMT.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.